Paeonol Attenuates Atherosclerosis by Inhibiting Vascular Smooth Muscle Cells Senescence via SIRT1/P53/TRF2 Signaling Pathway
Molecules · 04.01.2024 · 29 (1) · 261
DOI: 10.3390/molecules29010261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 04.01.2024. Verfasst von Min Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China. Hauptthemen laut MEDLINE: Sirtuins, Atherosclerosis, Acetophenones. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Anhui Province, Natural Science Program of Education Department of Anhui Province.
Abstract (Originalsprache)
Atherosclerosis is a chronic inflammatory disease leading to various vascular diseases. Vascular smooth muscle cell (VSMC) senescence promotes atherosclerotic inflammation and the formation of plaque necrosis core, in part through telomere damage mediated by a high-fat diet. Our previous research found that paeonol, a potential anti-inflammatory agent extracted from Cortex Moutan, could significantly improve VSMCs dysfunction. However, the impact of paeonol on the senescence of VSMCs remains unexplored. This study presents the protective effects of paeonol on VSMCs senescence, and its potential activity in inhibiting the progression of atherosclerosis in vivo and in vitro. Sirtuin 1 (SIRT1) is a nuclear deacetylase involved in cell proliferation, senescence, telomere damage, and inflammation. Here, SIRT1 was identified as a potential target of paeonol having anti-senescence and anti-atherosclerosis activity. Mechanistic studies revealed that paeonol binds directly to SIRT1 and then activates the SIRT1/P53/TRF2 pathway to inhibit VSMCs senescence. Our results suggested that SIRT1-mediated VSMCs senescence is a promising druggable target for atherosclerosis, and that pharmacological modulation of the SIRT1/P53/TRF2 signaling pathway by paeonol is of potential benefit for patients with atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China.
- Anhui Key Laboratory for Research and Development of Traditional Chinese Medicine, Hefei 230012, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Anhui Province
- Natural Science Program of Education Department of Anhui Province
Zitieren
APA
Zhou, M., Ma, X., Gao, M., Wu, H., Liu, Y., Shi, X., & Dai, M. (2024). Paeonol Attenuates Atherosclerosis by Inhibiting Vascular Smooth Muscle Cells Senescence via SIRT1/P53/TRF2 Signaling Pathway. Molecules, 29(1), 261. https://doi.org/10.3390/molecules29010261
Vancouver
Zhou M, Ma X, Gao M, Wu H, Liu Y, Shi X, et al. Paeonol Attenuates Atherosclerosis by Inhibiting Vascular Smooth Muscle Cells Senescence via SIRT1/P53/TRF2 Signaling Pathway. Molecules. 2024;29(1):261. doi:10.3390/molecules29010261
BibTeX
@article{Zhou2024,
author = {Zhou, Min and Ma, Xiaolin and Gao, Menglong and Wu, Hongfei and Liu, Yarong and Shi, Xiaoyan and Dai, Min},
title = {Paeonol Attenuates Atherosclerosis by Inhibiting Vascular Smooth Muscle Cells Senescence via SIRT1/P53/TRF2 Signaling Pathway},
journal = {Molecules},
year = {2024},
volume = {29},
number = {1},
pages = {261},
doi = {10.3390/molecules29010261}
}
EUVIMED